1. Population–versus Cohort–Based Modelling Approaches

   • Olivier Ethgen
   • Baudouin Standaert

   Current Opinion 11 October 2012 Pages: 171 - 181

   

2. Measuring Quality of Life in Patients with Schizophrenia

   • A. George Awad
   • Lakshmi N.P. Voruganti

   Leading Article 11 October 2012 Pages: 183 - 195

3. Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7

   • Frank R. Lichtenberg

   Leading Article 11 October 2012 Pages: 197 - 211

   

4. Pricing Human Papillomavirus Vaccines

   • Livio Garattini
   • Katelijne van de Vooren
   • Alessandro Curto

   Commentary 11 October 2012 Pages: 213 - 217

   

5. Methodological Quality of Economic Evaluations of New Pharmaceuticals in the Netherlands

   • Ties Hoomans
   • Johan L. Severens
   • Gepke O. Delwel

   Original Research Paper 11 October 2012 Pages: 219 - 227

   

6. Common Drug Review Recommendations

   • Angela Rocchi
   • Elizabeth Miller
   • Ron Goeree

   Original Research Paper 11 October 2012 Pages: 229 - 246

   

7. Rufinamide

   • Paul L. McCormack

   Original Research Paper 11 October 2012 Pages: 247 - 256